North America Analgesics Market Size is USD 16.98 Billion by 2026

North America Analgesics Market (By Drug Type: Opioid, Non-opioid, Compound Medication; By Route of Administration: Oral, Parenteral, Transdermal, Others; By Application: Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain Due to Burns, Dental/Facial, Pediatric, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Industry Size, Share, Growth, Trends 2025 to 2035

Report Code : 1606 | Published : 08 Jun 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 16.08 Bn

Forecast Year,

USD 27.73 Bn

CAGR, 2026 - 2035

5.60%

Report Coverage

North America

Download Databook

The North America analgesics market size was estimated at USD 16.08 billion in 2025 and is projected to be worth around USD 27.73 billion by 2035, is expanding at a CAGR of 5.60% from 2026 to 2035. Growing due to the high prevalence of chronic pain conditions and the increasing demand for over-the-counter pain relief solutions.

North America Analgesics Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 16.08 Billion
Market Size in 2026	USD 16.98 Billion
Market Size by 2035	USD 27.73 Billion
CAGR 2026 to 2035	5.60%
Base Year	2025
Forecast Period	2026 to 2035

Due to regulatory scrutiny of opioid use, there is a growing trend toward safer and non-opioid pain management options. Topical analgesics and combination therapies are also being used more frequently. The expansion of the market is further supported by the integration of digital health for pain monitoring.

The market is fueled by the high prevalence of chronic pain, the growing number of elderly people, and the robust demand for cutting-edge non-opioid pain patches treatments. Continuous product innovation and favorable reimbursement policies are contributing to the market's expansion.

Segments	Shares (%)
Opioid	46%
Non-opioid	38%
Compound Medication	16%

Opioid - Opioid segment is dominating with a market share of 46% driven by high adoption in severe and chronic pain management. Increasing prescription usage in post-surgical care is further supporting segment growth.
Non-opioid - Non opioid is fastest growing with a market share of 38% driven by rising preference for safer alternatives.
Compound Medication - Compound medication segment is notable with a market share of 16% driven by demand for personalized pain therapies. Advancements inn compounding pharmacies are further enhancing segment expansion.

Segments	Shares (%)
Oral	52%
Parenteral	24%
Transdermal	14%
Others	10%

Oral- Oral route is dominating with a market share of 52% driven by ease of administration and high patient compliance.
Parenteral- Parenteral route is fastest growing with a market share of 24% driven by increasing hospital-based treatments.
Transdermal - The transdermal route is notable with a market share of 14% driven by sustained drug delivery benefits.

Segments	Shares (%)
Musculoskeletal	22%
Surgical and Trauma-	16%
Cancer-	10%
Neuropathic	9%
Migraine	8%
Obstetrical	5%
Fibromyalgia	6%
Pain Due to Burns	4%
Dental/Facial	7%
Pediatric	6%
Others	7%

Musculoskeletal - Musculoskeletal segment is dominating with a market share of 22% driven by rising cases of arthritis and joint disorders.
Surgical and Trauma - Surgical and trauma segment is fastest growing, with a market share of 16% driven by increasing surgical procedures.
Cancer - Caner segment is notable with a market share of 10% driven by demand for palliative care. Rising cancer prevalence is further contributing to steady segment demand.

Segments	Shares (%)
Hospital Pharmacies	42%
Retail Pharmacies	38%
Online Pharmacies	20%

Hospital Pharmacies- Hospital pharmacies segment is dominating with a market share of 42% driven by higher inpatient treatments.
Retail Pharmacies- Retail pharmacies segment is fastest growing with a market share of 38% driven by increasing ITC drug sales.

Segments Covered in the Report

By Drug Type

Opioid
Non-opioid
Compound Medication

By Route of Administration

Oral
Parenteral
Transdermal
Others

By Application

Musculoskeletal
Surgical and Trauma
Cancer
Neuropathic
Migraine
Obstetrical
Fibromyalgia
Pain Due to Burns
Dental/Facial
Pediatric
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

List of Tables & Figures

List of Tables

Table 1: North America Analgesics Market Size, by Drug Type, 2025-2035 (USD Billion)
Table 2: North America Opioid Market Size, 2025-2035 (USD Billion)
Table 3: North America Non-opioid Market Size, 2025-2035 (USD Billion)
Table 4: North America Compound Medication Market Size, 2025-2035 (USD Billion)
Table 5: North America Analgesics Market Size, by Route of Administration, 2025-2035 (USD Billion)
Table 6: North America Oral Market Size, 2025-2035 (USD Billion)
Table 7: North America Parenteral Market Size, 2025-2035 (USD Billion)
Table 8: North America Transdermal Market Size, 2025-2035 (USD Billion)
Table 9: North America Others Market Size, 2025-2035 (USD Billion)
Table 10: North America Analgesics Market Size, by Application, 2025-2035 (USD Billion)
Table 11: North America Musculoskeletal Market Size, 2025-2035 (USD Billion)
Table 12: North America Surgical and Trauma Market Size, 2025-2035 (USD Billion)
Table 13: North America Cancer Market Size, 2025-2035 (USD Billion)
Table 14: North America Neuropathic Market Size, 2025-2035 (USD Billion)
Table 15: North America Migraine Market Size, 2025-2035 (USD Billion)
Table 16: North America Obstetrical Market Size, 2025-2035 (USD Billion)
Table 17: North America Fibromyalgia Market Size, 2025-2035 (USD Billion)
Table 18: North America Pain Due to Burns Market Size, 2025-2035 (USD Billion)
Table 19: North America Dental/Facial Market Size, 2025-2035 (USD Billion)
Table 20: North America Pediatric Market Size, 2025-2035 (USD Billion)
Table 21: North America Others Market Size, 2025-2035 (USD Billion)
Table 22: North America Analgesics Market Size, by Distribution Channel, 2025-2035 (USD Billion)
Table 23: North America Hospital Pharmacies Market Size, 2025-2035 (USD Billion)
Table 24: North America Retail Pharmacies Market Size, 2025-2035 (USD Billion)
Table 25: North America Online Pharmacies Market Size, 2025-2035 (USD Billion)
Table 26: U.S. Analgesics Market Size, 2025-2035 (USD Billion)
Table 27: Canada Analgesics Market Size, 2025-2035 (USD Billion)
Table 28: Mexico Analgesics Market Size, 2025-2035 (USD Billion)
Table 29: North America Market Share, by Drug Type, 2025 (%)
Table 30: North America Market Share, by Route of Administration, 2025 (%)
Table 31: North America Market Share, by Application, 2025 (%)
Table 32: North America Market Share, by Distribution Channel, 2025 (%)

List of Figures

Figure 1: North America Analgesics Market Share, by Drug Type, 2025 (%)
Figure 2: North America Analgesics Market Share, by Route of Administration, 2025 (%)
Figure 3: North America Analgesics Market Share, by Application, 2025 (%)
Figure 4: North America Analgesics Market Share, by Distribution Channel, 2025 (%)
Figure 5: North America Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 6: North America Opioid Market Forecast, 2025-2035 (USD Billion)
Figure 7: North America Non-opioid Market Forecast, 2025-2035 (USD Billion)
Figure 8: North America Compound Medication Market Forecast, 2025-2035 (USD Billion)
Figure 9: North America Oral Market Forecast, 2025-2035 (USD Billion)
Figure 10: North America Parenteral Market Forecast, 2025-2035 (USD Billion)
Figure 11: North America Transdermal Market Forecast, 2025-2035 (USD Billion)
Figure 12: North America Others Market Forecast, 2025-2035 (USD Billion)
Figure 13: North America Musculoskeletal Market Forecast, 2025-2035 (USD Billion)
Figure 14: North America Surgical and Trauma Market Forecast, 2025-2035 (USD Billion)
Figure 15: North America Cancer Market Forecast, 2025-2035 (USD Billion)
Figure 16: North America Neuropathic Market Forecast, 2025-2035 (USD Billion)
Figure 17: North America Migraine Market Forecast, 2025-2035 (USD Billion)
Figure 18: North America Obstetrical Market Forecast, 2025-2035 (USD Billion)
Figure 19: North America Fibromyalgia Market Forecast, 2025-2035 (USD Billion)
Figure 20: North America Pain Due to Burns Market Forecast, 2025-2035 (USD Billion)
Figure 21: North America Dental/Facial Market Forecast, 2025-2035 (USD Billion)
Figure 22: North America Pediatric Market Forecast, 2025-2035 (USD Billion)
Figure 23: North America Others Market Forecast, 2025-2035 (USD Billion)
Figure 24: North America Hospital Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 25: North America Retail Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 26: North America Online Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 27: U.S. Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 28: Canada Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 29: Mexico Analgesics Market Forecast, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026